ak 295 has been researched along with Brain Injuries in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartus, RT; Hayward, NJ; McIntosh, TK; Murai, H; Perri, BR; Saatman, KE; Smith, DH | 1 |
Bartus, RT; McIntosh, TK; Saatman, KE; Zhang, C | 1 |
2 other study(ies) available for ak 295 and Brain Injuries
Article | Year |
---|---|
Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat.
Topics: Animals; Brain Injuries; Calpain; Cognition Disorders; Cysteine Proteinase Inhibitors; Dipeptides; Disease Models, Animal; Male; Memory; Psychomotor Performance; Rats; Rats, Sprague-Dawley | 1996 |
Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis.
Topics: Animals; Apoptosis; Behavior, Animal; Brain Injuries; Calpain; Cerebral Cortex; Cysteine Proteinase Inhibitors; Dipeptides; Male; Peptide Hydrolases; Rats; Rats, Sprague-Dawley; Spectrin | 2000 |